Sign up to save your podcasts
Or
Share The High Dose Aflibercept DME Trial
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
The High Dose Aflibercept DME Trial
We discuss the baseline characteristics of eyes in the HD Aflibercept Phase III clinical trial and examine their ability for extended dosing with Dr. Eric Schneider of Tennessee Retina, Nashville, TN.
View all episodes
By Retina Synthesis
4.5
88 ratings
We discuss the baseline characteristics of eyes in the HD Aflibercept Phase III clinical trial and examine their ability for extended dosing with Dr. Eric Schneider of Tennessee Retina, Nashville, TN.
More shows like Retina Synthesis
View all
Ophthalmology off the Grid by Eyetube
43 Listeners
New Retina Radio by Eyetube
18 Listeners
Straight From The Cutter's Mouth: A Retina Podcast
97 Listeners
The Daily
112,482 Listeners
Up First from NPR
56,742 Listeners
JAMA Ophthalmology Author Interviews
5 Listeners
The Indicator from Planet Money
9,570 Listeners
The Retina Channel Podcast
11 Listeners
Dateline NBC
47,692 Listeners
Experts InSight
50 Listeners
RETINA Journal Podcasts
11 Listeners
Knock Knock, Hi! with the Glaucomfleckens
464 Listeners
Ophthalmology Journal
19 Listeners
ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum
0 Listeners